H Li1, F-Y Liu, X-L Li, L Zhu, H Zhou. 1. Department of Cardiovascularology, Xiangyang Hospital Affiliated to Hubei University of Medicine, Xiangyang, Hubei, China. 3404617lihui@163.com.
Abstract
OBJECTIVE: To investigate peri-cardiocentesis and glucocorticoids in the treat-ment of the clinical curative effect of tubercu-lous pericarditis. PATIENTS AND METHODS: Choose 128 cases of our hospital diagnosed as tuberculous peri-carditis patients as the research object, accord-ing to the treatment, were divided into group A (pericardium puncture + anti-tuberculosis (an-ti-TB) treatment of 26 cases) and group B (peri-cardium puncture +anti-tuberculosis (anti-TB) + glucocorticoid treatment of 30 cases), group C (anti-tuberculosis (anti-TB) + glucocorticoid therapy of 24 cases, and group D anti-tuberculo-sis (anti-TB) treatment of 48 cases, in the treat-ment of 8 weeks, 3 months, 6 months, 9 months, 12 months, 18 months by B ultrasonic and CT ex-amination to observe the efficacy of treatment. RESULTS: At 8 weeks after treatment in group A, group B and group C and group D efficient were 61.54%, 93.33%, 54.17%, and 68.75%, respective-ly, group B, respectively, compared with group A, group C, and group D, had obvious statistical sig-nificance difference (p < 0.05); Groups of early and late treatment comparison difference have no sta-tistical significance (p > 0.05). CONCLUSIONS:Tuberculous pericarditis in anti-TB treatment on the basis of using pericar-diocentesis and sugar cortical hormone treat-ment, can achieve an ideal effect.
RCT Entities:
OBJECTIVE: To investigate peri-cardiocentesis and glucocorticoids in the treat-ment of the clinical curative effect of tubercu-lous pericarditis. PATIENTS AND METHODS: Choose 128 cases of our hospital diagnosed as tuberculous peri-carditis patients as the research object, accord-ing to the treatment, were divided into group A (pericardium puncture + anti-tuberculosis (an-ti-TB) treatment of 26 cases) and group B (peri-cardium puncture +anti-tuberculosis (anti-TB) + glucocorticoid treatment of 30 cases), group C (anti-tuberculosis (anti-TB) + glucocorticoid therapy of 24 cases, and group D anti-tuberculo-sis (anti-TB) treatment of 48 cases, in the treat-ment of 8 weeks, 3 months, 6 months, 9 months, 12 months, 18 months by B ultrasonic and CT ex-amination to observe the efficacy of treatment. RESULTS: At 8 weeks after treatment in group A, group B and group C and group D efficient were 61.54%, 93.33%, 54.17%, and 68.75%, respective-ly, group B, respectively, compared with group A, group C, and group D, had obvious statistical sig-nificance difference (p < 0.05); Groups of early and late treatment comparison difference have no sta-tistical significance (p > 0.05). CONCLUSIONS:Tuberculous pericarditis in anti-TB treatment on the basis of using pericar-diocentesis and sugar cortical hormone treat-ment, can achieve an ideal effect.